Inventor · disambiguated record
Toshihiko Takeuchi
Also filed as: TAKEUCHI TOSHIHIKO
23 granted patents·12 pending applications·250 citations·filing 1995–2023
95Inventor score
Top patents by PatentIndex Score
35 records- 0195US7227009B2MT-SP1 polynucleotides and polypeptidesCATALYST BIOSCIENCES INC·Filed 2005·Granted Jun 5, 2007·35 cites·9 claims
- 0293US7030231B1Membrane type serine protease 1 (MT-SP1) and uses thereofCATALYST BIOSCIENCES INC·Filed 1999·Granted Apr 18, 2006·90 cites·6 claims
- 0391US8569462B2Antibodies specific for TGF-beta and methods for treating thereofBEDINGER DANIEL·Filed 2012·Granted Oct 29, 2013·28 cites·21 claims
- 0488US10251933B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2018·Granted Apr 9, 2019·4 cites·18 claims
- 0588US8216571B2Fully human anti-VEGF antibodies and methods of usingRAMACHANDRA SUMANT·Filed 2008·Granted Jul 10, 2012·29 cites·21 claims
- 0687US9145458B2Antibodies specific for TGF-β and methods of treatment thereofXOMA TECHNOLOGY LTD·Filed 2013·Granted Sep 29, 2015·7 cites·24 claims
- 0786US9714285B2TGF-beta-specific antibodies and methods of use thereof for treatmentXOMA TECHNOLOGY LTD·Filed 2015·Granted Jul 25, 2017·4 cites·20 claims
- 0885US7285640B2Antibody to stem cell factorBAYER CORP·Filed 2002·Granted Oct 23, 2007·12 cites·7 claims
- 0982US10358486B2Nucleic acids encoding, and methods of producing, antibodies specific for transforming growth factor (TGF)-βXOMA TECHNOLOGY LTD·Filed 2017·Granted Jul 23, 2019·2 cites·20 claims
- 1080US10253101B2Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemiaXOMA US LLC·Filed 2016·Granted Apr 9, 2019·2 cites·33 claims
- 1178US12071475B2Antibodies that bind transforming growth factor beta (TGF beta) and methods of use thereof for treatmentXOMA TECHNOLOGY LTD·Filed 2021·Granted Aug 27, 2024·0 cites·19 claims
- 1277US11207376B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2018·Granted Dec 28, 2021·1 cites·24 claims
- 1377US9102711B2Methods and materials for targeted mutagenesisTAKEUCHI TOSHIHIKO·Filed 2008·Granted Aug 11, 2015·2 cites·8 claims
- 1477US6008190ACobalt Schiff base compoundsCALIFORNIA INST OF TECHN·Filed 1995·Granted Dec 28, 1999·21 cites·21 claims
- 1575US10858428B2Antibodies that bind interleukin-2 and uses thereofXOMA US LLC·Filed 2017·Granted Dec 8, 2020·2 cites·31 claims
- 1674US2024066095A1Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2023·Application pending·0 cites
- 1773US2024158535A1Parathyroid hormone receptor 1(pth1r) antibodies and uses thereofXOMA US LLC·Filed 2023·Application pending·0 cites
- 1871US11098111B2Method of treating cancer by administering an antibody that binds transforming growth factor beta (TGF-beta) 1, TGF-beta 2 and TGF-beta 3XOMA TECHNOLOGY LTD·Filed 2019·Granted Aug 24, 2021·0 cites·24 claims
- 1971US10519250B2Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereofXOMA US LLC·Filed 2017·Granted Dec 31, 2019·1 cites·34 claims
- 2071US7462696B2Human antibodies that have MN binding and cell adhesion-neutralizing activityBAYER PHARMACEUTICAL CORP·Filed 2002·Granted Dec 9, 2008·9 cites·10 claims
- 2170US11787876B2Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereofXOMA US LLC·Filed 2019·Granted Oct 17, 2023·0 cites·24 claims
- 2270US11666627B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2019·Granted Jun 6, 2023·1 cites·16 claims
- 2365US2009155248A1Antibodies to MT-SP1 serine proteaseUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 2462US12234285B2Antibodies that bind interleukin-2 and uses thereofXOMA US LLC·Filed 2020·Granted Feb 25, 2025·0 cites·14 claims
- 2560US2008051559A1MT-SP1 polypeptidesUNIV CALIFORNIA·Filed 2007·Application pending·0 cites
- 2656US2010240100A1Human antibodies that have mn binding and cell adhesion-neutralizing activityTAKEUCHI TOSHIHIKO·Filed 2008·Application pending·0 cites
- 2756US2005112698A1Antibody inhibiting stem cell factor activity and use for treatment of asthmaFiled 2004·Application pending·0 cites
- 2853US2024317816A1Peptides for immunotherapyGENEVIVE INC·Filed 2022·Application pending·0 cites
- 2951US2018251562A1Antibody Fragments Against the Insulin Receptor and Uses Thereof to Treat HypoglycemiaXOMA US LLC·Filed 2018·Application pending·0 cites
- 3051US2009215639A1Method of Producing Human IgG Antibodies with Enhanced Effector FunctionsBIOREN INC·Filed 2006·Application pending·0 cites
- 3149US2012107871A1Method of producing human igg antibodies with enhanced effector functionsCREA ROBERTO·Filed 2011·Application pending·0 cites
- 3245US2023272016A1Peptides for immunotherapySECOND GENOME INC·Filed 2021·Application pending·0 cites
- 3342US2006024308A1High affinity anti-TNF-alpha antibodies and methodCREA ROBERTO·Filed 2005·Application pending·0 cites
- 3441US11674240B2Universal antibody librariesCREA ROBERTO·Filed 2005·Granted Jun 13, 2023·0 cites·8 claims
- 3540US9732143B2Methods and materials for enhancing functional protein expression in bacteriaLEVY RAPHAEL D·Filed 2012·Granted Aug 15, 2017·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Toshihiko Takeuchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →